{"id":569075,"date":"2026-10-02T02:00:00","date_gmt":"2026-10-02T00:00:00","guid":{"rendered":"https:\/\/medizinonline.com\/natural-substance-based-nanomedicine-for-ischemic-heart-disease\/"},"modified":"2026-10-08T17:55:38","modified_gmt":"2026-10-08T15:55:38","slug":"natural-substance-based-nanomedicine-for-ischemic-heart-disease","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/en\/natural-substance-based-nanomedicine-for-ischemic-heart-disease\/","title":{"rendered":"Natural-Substance-Based Nanomedicine for Ischemic Heart Disease"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>Nanoformulated natural substances are among the fields that are widely published on but rarely addressed. A recent review article in <em>the Journal of Nanobiotechnology<\/em> has summarized the state of research on ischemic heart disease, ranging from delivery systems to preclinical applications and the hurdles to clinical translation [1]. The most sobering statement in the paper appears in the chapter on these hurdles: In the field of clinical translation of nanomedicines, fewer than five percent of projects ever reach the clinical trial phase [1,2].<\/strong><\/p>\n\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/en\/my-account\/packages\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/en\/log-in\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fen%2Fnatural-substance-based-nanomedicine-for-ischemic-heart-disease%2F\">Log in here<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>Nanoformulated natural substances are among the fields that are widely published on but rarely addressed. A recent review article in the Journal of Nanobiotechnology has summarized the state of research&#8230;&hellip;... <\/p>\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/en\/my-account\/packages\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/en\/log-in\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fen%2Fnatural-substance-based-nanomedicine-for-ischemic-heart-disease%2F\">Log in here<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":569076,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Why Less Than Five Percent of Projects Make It to the Clinic","footnotes":"","_members_access_role":[],"_members_access_error":""},"category":[11548,11359,11508,11447,11442,74319,11503],"tags":[102491,74020,102488,102487,85283,102486,102492,102490,102489],"powerkit_post_featured":[],"class_list":["post-569075","post","type-post","status-publish","format-standard","has-post-thumbnail","category-rx-en","category-cardiology","category-education","category-pharmaceutical-medicine","category-pharmacology-and-toxicology","category-phytotherapy","category-studies","tag-alkaloids","tag-flavonoids","tag-ischemic-heart-disease","tag-nanocarrier","tag-nanomedicine","tag-natural-substances","tag-phenolic-acid","tag-saponins","tag-terpenoids","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-10-16 01:02:33","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"en_US","wpml_translations":{"fr_FR":{"locale":"fr_FR","id":569078,"slug":"la-nanomedecine-a-base-de-substances-naturelles-dans-le-traitement-des-cardiopathies-ischemiques","post_title":"La nanom\u00e9decine \u00e0 base de substances naturelles dans le traitement des cardiopathies isch\u00e9miques","href":"https:\/\/medizinonline.com\/fr\/la-nanomedecine-a-base-de-substances-naturelles-dans-le-traitement-des-cardiopathies-ischemiques\/"},"it_IT":{"locale":"it_IT","id":569081,"slug":"nanomedicina-a-base-di-sostanze-naturali-nella-cardiopatia-ischemica","post_title":"Nanomedicina a base di sostanze naturali nella cardiopatia ischemica","href":"https:\/\/medizinonline.com\/it\/nanomedicina-a-base-di-sostanze-naturali-nella-cardiopatia-ischemica\/"},"pt_PT":{"locale":"pt_PT","id":569057,"slug":"nanomedicina-a-base-de-substancias-naturais-no-tratamento-da-doenca-cardiaca-isquemica","post_title":"Nanomedicina \u00e0 base de subst\u00e2ncias naturais no tratamento da doen\u00e7a card\u00edaca isqu\u00e9mica","href":"https:\/\/medizinonline.com\/pt-pt\/nanomedicina-a-base-de-substancias-naturais-no-tratamento-da-doenca-cardiaca-isquemica\/"},"es_ES":{"locale":"es_ES","id":569064,"slug":"nanomedicina-basada-en-sustancias-naturales-para-la-cardiopatia-isquemica","post_title":"Nanomedicina basada en sustancias naturales para la cardiopat\u00eda isqu\u00e9mica","href":"https:\/\/medizinonline.com\/es\/nanomedicina-basada-en-sustancias-naturales-para-la-cardiopatia-isquemica\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts\/569075","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/comments?post=569075"}],"version-history":[{"count":1,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts\/569075\/revisions"}],"predecessor-version":[{"id":569077,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts\/569075\/revisions\/569077"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/media\/569076"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/media?parent=569075"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/category?post=569075"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/tags?post=569075"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/powerkit_post_featured?post=569075"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}